Survival following Treatment of Aortoesophageal Fistula with Dual Esophageal and Aortic Intervention by Ghosh, Soumitra K. et al.
 
Case Rep Gastroenterol 2011;5:40–44 
DOI: 10.1159/000323700 
Published online: 
January 14, 2011 
© 2011 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
This is an Open Access article licensed under the terms of the Creative Commons Attribution-
NonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable to the online 
version of the article only. Distribution for non-commercial purposes only. 
 
Soumitra K. Ghosh    University College Hospital London  
London NW1 2BU (UK) 
Tel. +44 7731 886 572, E-Mail skghosh @ doctors.org.uk 
 
40
   
Survival following Treatment 
of Aortoesophageal Fistula with 
Dual Esophageal and Aortic 
Intervention 
Soumitra K. Ghosha    Farooq Z. Rahmana    Stephen Bowna, c   
Peter Harrisb    Kevin Fongd    Louise Langmeada 
aDepartment of Gastroenterology, bDepartment of Vascular Surgery, 
cNational Medical Laser Centre, and dDepartment of Anaesthetics, 
University College Hospital, London, UK 
 
Key Words 
Esophageal cancer · Aortoesophageal fistula · Gastrointestinal bleed · Esophageal stent 
Abstract 
Aortoesophageal fistulas are a rare but commonly fatal complication of esophageal 
cancer. Reports of successfully managed cases are few, with high mortality and morbidity 
usually resulting from failure to control the initial massive haemodynamic insult. We 
report the case of a 47-year-old Caucasian man with recently diagnosed advanced 
esophageal cancer who suffered an episode of massive haematemesis. Emergency 
gastroscopy revealed an arterial bleeding point in the proximal esophagus. A 
self-expanding metal esophageal stent was placed to achieve initial partial haemostasis. 
CT angiography confirmed an aortoesophageal fistula. An endoluminal stent device was 
thus inserted within the thoracic aorta stabilising the bleeding point. The patient 
subsequently made an uneventful recovery and was discharged on long-term antibiotics 
for palliative care. He survived for 2 months at home before dying of disseminated 
malignancy. The successful use of esophageal stenting as a means of achieving 
haemostasis, allowing time for endovascular intervention, is as yet a relatively 
unexplored area of management of this rare condition. 
Introduction 
Aortoesophageal fistula is a rare, devastating and usually fatal condition which has 
multiple aetiological factors. The first report, in 1818, described the death of a 28-year-old 
soldier who exsanguinated after ingesting a beef bone fragment [1]. A comprehensive 
review, published by Hollander and Quick [2], which included 500 cases of fistula,  
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identified three major causes of aortoesophageal fistula, the main aetiologic factor being 
aortic disease with 54.2% of cases secondary to rupture of a descending thoracic aorta 
aneurysm into the oesophagus. Foreign body ingestion (19.2%) and advanced esophageal 
carcinoma (17.0%) were the next commonest causes. 
Regardless of cause, the optimal management of the fistula remains controversial, and 
recent literature has focused on the role of endovascular techniques and open thoracic 
surgery [3]. However, high mortality from the condition usually results from massive 
uncontrolled haemorrhage prior to these interventions being possible. Although 
non-surgical measures to control the initial haemodynamic insult caused by haemorrhage 
have been described [3], this remains a relatively unexplored area of management [4]. 
Case Report 
A 47-year-old Caucasian man with recently diagnosed advanced esophageal cancer attended the 
imaging department for an ultrasound scan. In the waiting area, the patient had a massive haematemesis 
and proceeded into a peri-arrest state. 
He initially presented two months earlier with progressive dysphagia and weight loss. Significant 
past medical history included smoking and previous opioid dependence. Gastroscopy revealed a 
stricturing exophytic mid-esophageal lesion with an apparent fistula. A 12 × 12 Hanaro covered stent 
(M.I. Tech, Seoul, distributed by MTW, Wesel, Germany) was inserted across the lesion. CT confirmed 
an esophageal tumour in continuity with the right main bronchus with an associated right lung abscess. 
Despite esophageal stenting the patient developed worsening dysphagia in the following weeks. Repeat 
gastroscopy identified tumour overgrowth at and over the top of the original stent. An overlapping fully 
covered 12 × 18 Alveolus Aero stent (Alveolus, Charlotte, N.C., USA) was inserted. Despite treatment 
with intravenous antibiotics, an empyema subsequently developed (fig. 1), presumably because the 
bronchial fistula had been adequately sealed with the stents, creating an undrained collection in the 
lung which subsequently fistulated through to the pleural cavity. While awaiting a video-assisted 
thoracoscopic surgical procedure to drain and seal the abscess and empyema, he spontaneously drained 
the abscess by coughing up nearly 1 litre of pus in 24 h; this led to a dramatic improvement in his 
clinical state and resolution of his chest X-ray changes. He was discharged on antibiotics and further 
staging investigations were scheduled as an outpatient. A week before the ultrasound scan he 
experienced mid-thoracic pain and small episodes of haematemesis.  
When he collapsed, he was tachycardic (heart rate 128 bpm) with unrecordable blood pressure. 
Fluid resuscitation was commenced. The patient was anaesthetised and transferred for emergency 
gastroscopy. This revealed an esophageal lumen full of clotted blood. Its clearance identified a large 
arterial bleeding point, just above the proximal end of the stent in the mid-esophagus (fig. 2a). A 
further 28 mm diameter Niti-S covered esophageal stent (Taewong Medical, Seoul, Korea) was inserted 
to tamponade the bleeding point (fig. 2b). Despite aggressive resuscitation with fluids and 8 units of 
blood, there was no improvement in his haemodynamic status until after stent deployment. The patient 
was transferred to the intensive care unit where fresh bleeding continued to be aspirated from his 
nasogastric tube overnight. A further 8 units of blood and 6 units of fresh frozen plasma were transfused 
to maintain his haemoglobin between 7 and 7.7 g/dl. With this, he remained haemodynamically stable 
(mean arterial blood pressure 60–80 mm Hg). 
CT angiography was performed and demonstrated an aortoesophageal fistula at the level of the 
carina with ongoing bleeding into the mediastinum (fig. 3a). An endoluminal vascular stent (COOK 
TX2 36 mm × 120) was inserted into the thoracic aorta distal to the origin of the left subclavian artery 
sealing the fistula. Repeat CT angiography confirmed haemostasis (fig. 3b). The patient was discharged 
on long-term antibiotics for palliative care. He survived for 2 months at home, during which he was able 
to attend to his personal affairs, before dying of disseminated malignancy.  
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Discussion 
This case highlights the successful non-surgical management of a massive bleed caused 
by aortoesophageal fistula. The esophageal stent acted as a means to tamponade and 
provided partial initial control of the bleeding point. This allowed time for appropriate 
endovascular intervention in the form of a thoracic endoluminal stent device to further 
stabilise the haemodynamic status of the patient.  
The challenge to recognise and treat successfully before the patient exsanguinates is 
probably why success stories for closure of aortoesophageal fistulas are few. High clinical 
suspicion and recognition of warning symptoms such as mid-thoracic pain and sentinel 
arterial upper gastrointestinal haemorrhage is crucial [5]. Transient self-limiting ‘herald’ 
bleeds may precede fatal exsanguination by more than 24 h [6]. This ‘window of 
opportunity’ allows early transfer to a specialist centre. High clinical suspicion and 
recognition of warning symptoms is essential. 
Since Parodi et al. first reported using an endoluminal stent graft for repair of 
abdominal aortic aneurysms [7], thoracic endovascular aortic repair (TEVAR) has 
become more common in the management of aortoesophageal fistula [3], with much of 
the literature focusing on endovascular and open surgical management. There is still an 
ongoing debate as to the appropriate role of these interventions [8]. A recently reported 
successful surgical approach [9] advocated open transthoracic esophageal resection, 
cervical esophagectomy and gastrostomy. The patient had developed a fistula secondary 
to previous TEVAR, so the authors could not decide the best approach to salvage the 
thoracic aorta. Although successful in stabilising the patient, this highly invasive approach 
may not be suitable for patients with advanced esophageal malignancy. 
Less invasive successful endovascular management of fistulas in patients with 
esophageal malignancy has been reported. One report [10] describes the use of a Dacron 
prosthesis interposed into the descending thoracic aorta to restore aortic flow as 
successful endovascular intervention; the same patient later underwent an esophagectomy 
for definitive treatment. A separate report [11] describes successful endovascular 
intervention to stabilise bleeding, although again this patient also went on to require 
further definitive gastrointestinal surgical management. 
Further reports [9–11] appear to suggest that although TEVAR is a useful method 
for achieving hemodynamic stability, for definitive long-term management the patient 
will require some form of open surgical intervention. Of course with advanced esophageal 
malignancy, patients may simply not be suitable for surgery, leaving TEVAR as their 
only option. The problem with TEVAR remains that it does not prevent immediate 
exsanguination in patients admitted with fistula. It was found in patients who underwent 
TEVAR that early esophageal repair appeared to improve survival [12]. Literature on 
the successful esophageal management of the initial exsanguination remains limited, 
with the successful use of a Sengstaken-Blakemore tube prior to TEVAR being reported 
[13]. Newer techniques have been emerging, such as the use of cyanoacrylate 
embolisation of the fistula followed by TEVAR [14]. The use of esophageal stenting as a 
means of controlling initial exsanguination remains a relatively unexplored area of 
management.  
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In conclusion, with early recognition, esophageal stenting may have a role in the initial 
emergency control of bleeding due to aortoesophageal fistula, but clearly, immediate 
access to anaesthetic, interventional endoscopic and radiological services is mandatory. 
Further surgical or endovascular intervention would then be essential. 
 
 
 
 
 
 
Fig. 1. Chest X-ray showing development of a right-sided empyema in the patient. 
 
 
 
Fig. 2. Endoscopic images. a A large arterial bleeding point (arrow), just above the proximal end of the 
stent in the mid-esophagus. The jet of blood, which was reckoned to be almost 2 mm in diameter, goes 
from the bottom left hand corner to the middle of the top left hand quadrant. b A 28 mm diameter 
Niti-S covered esophageal stent (Taewong Medical, Seoul, Korea) was inserted to tamponade the 
bleeding point. 
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Fig. 3. CT angiography images. a An aortoesophageal fistula at the level of the carina with ongoing 
bleeding into the mediastinum. The esophagus is filled with old clot without contrast, indicating 
successful tamponade of the fistula. b An endoluminal vascular stent (COOK TX2 36 mm × 120) was 
inserted into the thoracic aorta distal to the origin of the left subclavian artery sealing the fistula. Repeat 
CT angiography confirmed haemostasis. 
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